About Enhancer

Enhancer ID: E_01_0542
Species: human
Position : chr8:116843661-116845661
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: Nothing
Pubmed ID:  29670286
Enhancer experiment: ChIP,ChIPseq,PRO-cap,Enhancer reporter assay,CRSIPR/Cas9,qRTPCR,RNA-seq,MeDIPseq,4Cseq,ATAC-seq,Deep sequencing,Bioinformatic characterization of enhancers,western blot,
Enhancer experiment description: Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.

About Target gene

Target gene : RAD21,ESRRB,NANOG(NANOG),ZFX
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.;Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.;Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.;Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.;Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.;Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.;Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.;Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.;Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.

About TF

TF name : SOX2(ANOP3,MCOPS3)SMAD1(AI528653,Mad1,Madh1,Madr1,Mlp1,MusMLP,dwf-A,mMad1)E2F1(E2F-1,RBAP1,RBBP3,RBP3)STAT3(ADMIO,ADMIO1,APRF,HIES)KLF4(EZF,GKLF)
TF experiment: ChIP,ChIPseq,PRO-cap,Enhancer reporter assay,CRSIPR/Cas9,qRTPCR,RNA-seq,MeDIPseq,4Cseq,ATAC-seq,Deep sequencing,Bioinformatic characterization of enhancers,western blot,
TF experiment description: Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.;Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.;Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.;Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.;Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.;Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.;Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.;Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.;Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.

About Function

Enhancer function : Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
Here we show that cell-type-restricted enhancers are 'premarked' and activated as transcription units by the binding of one or two ES cell transcription factors, although they do not exhibit traditional enhancer epigenetic marks in ES cells, thus uncovering the initial temporal origins of cell-type-restricted enhancers. This premarking is required for future cell-type-restricted enhancer activity in the differentiated cells, with the strength of the ES cell signature being functionally important for the subsequent robustness of cell-type-restricted enhancer activation. We have experimentally validated this model in macrophage-restricted enhancers and neural precursor cell (NPC)-restricted enhancers using ES cell-derived macrophages or NPCs, edited to contain specific ES cell transcription factor motif deletions. DNA hydroxyl-methylation of enhancers in ES cells, determined by ES cell transcription factors, may serve as a potential molecular memory for subsequent enhancer activation in mature macrophages. These findings suggest that the massive repertoire of cell-type-restricted enhancers are essentially hierarchically and obligatorily premarked by binding of a defining ES cell transcription factor in ES cells, dictating the robustness of enhancer activation in mature cells.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number
SOX2 Deactivation of the beta-catenin transactivating complex reactome 42
SOX2 POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation reactome 13
SOX2 POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation reactome 10
SOX2 Transcriptional regulation of pluripotent stem cells reactome 28
SOX2 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
SOX2 Hs_Dopaminergic_Neurogenesis_WP2855_87239 wikipathways 19
SOX2 Hs_Wnt_Signaling_Pathway_and_Pluripotency_WP399_90291 wikipathways 12
SOX2 Hs_Mesodermal_Commitment_Pathway_WP2857_87780 wikipathways 47
SOX2 Hs_Ectoderm_Differentiation_WP2858_89329 wikipathways 56
SMAD1 ALK1 signaling events pid 26
SMAD1 ALK2 signaling events pid 11
SMAD1 BMP receptor signaling pid 42
SMAD1 BMP signaling pathway ( TGF-beta_BMP Diagram(MolecularVariation) ) inoh 34
SMAD1 BMP2 signaling pathway(through Smad) ( TGF-beta_BMP Diagram(MolecularVariation) ) inoh 13
SMAD1 ErbB1 downstream signaling pid 105
SMAD1 Gene expression of smad6/7 by R-smad:smad4 ( TGF-beta_super_family_signaling_pathway(canonical) ) inoh 8
SMAD1 Gene expression of smad7 by R-smad:smad4 ( TGF-beta_super_family_signaling_pathway(canonical) ) inoh 7
SMAD1 Hedgehog netpath 39
SMAD1 LIF signaling pathway ( LIF signaling(JAK1 JAK2 STAT3) ) inoh 10
SMAD1 Negative regulation of (nuclear import of R-smad:smad4) in TGF beta super family signaling pathway ( TGF-beta_super_family_signaling_pathway(canonical) ) inoh 11
SMAD1 Negative regulation of (transcription by R-smad:smad4) in TGF beta super family signaling pathway ( TGF-beta_super_family_signaling_pathway(canonical) ) inoh 21
SMAD1 Notch netpath 76
SMAD1 Signaling by BMP reactome 23
SMAD1 TGF-beta signaling pathway panther 88
SMAD1 TGF-beta_super_family_signaling_pathway(canonical) ( TGF-beta_BMP Diagram(MolecularVariation) ) inoh 51
SMAD1 Wnt netpath 118
SMAD1 Wnt signaling pathway panther 250
SMAD1 TGF-beta signaling pathway kegg 82
SMAD1 Hs_Integrated_Breast_Cancer_Pathway_WP1984_82941 wikipathways 122
SMAD1 Hs_Neural_Crest_Differentiation_WP2064_79263 wikipathways 40
SMAD1 Hs_Heart_Development_WP1591_90186 wikipathways 28
SMAD1 Hs_Bone_Morphogenic_Protein_(BMP)_Signalling_and_Regulation_WP1425_86082 wikipathways 6
SMAD1 Hs_G13_Signaling_Pathway_WP524_72112 wikipathways 18
SMAD1 Hs_Mesodermal_Commitment_Pathway_WP2857_87780 wikipathways 47
E2F1 Activation of PUMA and translocation to mitochondria reactome 8
E2F1 Association of licensing factors with the pre-replicative complex reactome 15
E2F1 Calcineurin-regulated NFAT-dependent transcription in lymphocytes pid 50
E2F1 CDC6 association with the ORC:origin complex reactome 11
E2F1 Cyclin D associated events in G1 reactome 38
E2F1 Direct p53 effectors pid 141
E2F1 E2F mediated regulation of DNA replication reactome 17
E2F1 E2F transcription factor network pid 77
E2F1 G0 and Early G1 reactome 25
E2F1 G1/S-Specific Transcription reactome 17
E2F1 G2 Phase reactome 5
E2F1 IL2 signaling events mediated by PI3K pid 38
E2F1 Inhibition of replication initiation of damaged DNA by RB1/E2F1 reactome 12
E2F1 Notch-mediated HES/HEY network pid 48
E2F1 Oncogene Induced Senescence reactome 30
E2F1 Oxidative Stress Induced Senescence reactome 120
E2F1 p75(NTR)-mediated signaling pid 74
E2F1 Pre-NOTCH Transcription and Translation reactome 29
E2F1 Regulation of retinoblastoma protein pid 67
E2F1 Regulation of Telomerase pid 70
E2F1 TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest reactome 13
E2F1 Cell cycle kegg 124
E2F1 Pathways in cancer kegg 321
E2F1 Pancreatic cancer kegg 70
E2F1 Glioma kegg 65
E2F1 Prostate cancer kegg 85
E2F1 Melanoma kegg 69
E2F1 Bladder cancer kegg 38
E2F1 Chronic myeloid leukemia kegg 69
E2F1 Small cell lung cancer kegg 83
E2F1 Non-small cell lung cancer kegg 54
E2F1 Hs_DNA_Damage_Response_WP707_82937 wikipathways 28
E2F1 Hs_miRNA_Regulation_of_DNA_Damage_Response_WP1530_84694 wikipathways 28
E2F1 Hs_miRNAs_involved_in_DNA_damage_response_WP1545_84697 wikipathways 30
E2F1 Hs_Endochondral_Ossification_WP474_87977 wikipathways 43
E2F1 Hs_Integrated_Breast_Cancer_Pathway_WP1984_82941 wikipathways 122
E2F1 Hs_Integrated_Cancer_Pathway_WP1971_82939 wikipathways 33
E2F1 Hs_DNA_IR-Double_Strand_Breaks_(DSBs)_and_cellular_response_via_ATM_WP3959_91367 wikipathways 50
E2F1 Hs_Bladder_Cancer_WP2828_89143 wikipathways 17
E2F1 Hs_Signaling_Pathways_in_Glioblastoma_WP2261_89520 wikipathways 16
E2F1 Hs_Aryl_Hydrocarbon_Receptor_WP2586_91687 wikipathways 16
E2F1 Hs_Fatty_Acid_Beta_Oxidation_WP143_79783 wikipathways 14
E2F1 Hs_EGF-EGFR_Signaling_Pathway_WP437_79266 wikipathways 107
STAT3 AndrogenReceptor netpath 167
STAT3 Angiogenesis panther 141
STAT3 Association of TriC/CCT with target proteins during biosynthesis reactome 39
STAT3 BCR netpath 161
STAT3 BMP2 signaling pathway(through Smad) ( TGF-beta_BMP Diagram(MolecularVariation) ) inoh 13
STAT3 CXCR4-mediated signaling events pid 87
STAT3 Downstream signal transduction reactome 29
STAT3 EGF receptor signaling pathway panther 109
STAT3 EGFR1 netpath 475
STAT3 EPO signaling pathway(JAK2 STAT1 STAT3 STAT5) ( EPO signaling pathway(JAK2 STAT1 STAT3 STAT5) ) inoh 12
STAT3 ErbB1 downstream signaling pid 105
STAT3 ErbB2/ErbB3 signaling events pid 41
STAT3 FGF signaling pathway pid 55
STAT3 Gene expression of SOCS by STAT dimer ( JAK-STAT pathway and regulation pathway Diagram ) inoh 14
STAT3 Gene expression of SOCS1 by STAT dimer ( JAK-STAT pathway and regulation pathway Diagram ) inoh 8
STAT3 Gene expression of SOCS3 by STAT dimer ( JAK-STAT pathway and regulation pathway Diagram ) inoh 8
STAT3 GMCSF-mediated signaling events pid 38
STAT3 Growth hormone receptor signaling reactome 24
STAT3 IFN-gamma pathway pid 43
STAT3 IFN alpha signaling pathway(JAK1 TYK2 STAT1 STAT3) ( IFN alpha signaling(JAK1 TYK2 STAT1 STAT2 STAT3) ) inoh 19
STAT3 IFN alpha signaling pathway(JAK1 TYK2 STAT3) ( IFN alpha signaling(JAK1 TYK2 STAT1 STAT2 STAT3) ) inoh 18
STAT3 IL-10 signaling pathway(JAK1 TYK2 STAT3) ( IL-10 signaling(JAK1 TYK2 STAT3) ) inoh 6
STAT3 IL-23 signaling pathway(JAK2 TYK2 STAT3 STAT4) ( IL-23 signaling(JAK2 TYK2 STAT3 STAT4) ) inoh 6
STAT3 IL-6 signaling pathway(JAK1 JAK2 STAT3) ( IL-6 signaling(JAK1 JAK2 STAT3) ) inoh 6
STAT3 IL-7 netpath 28
STAT3 IL1 netpath 69
STAT3 IL12-mediated signaling events pid 62
STAT3 IL12 signaling mediated by STAT4 pid 33
STAT3 IL2-mediated signaling events pid 54
STAT3 IL2 netpath 81
STAT3 IL23-mediated signaling events pid 37
STAT3 IL27-mediated signaling events pid 26
STAT3 IL3 netpath 84
STAT3 IL4 netpath 75
STAT3 IL5 netpath 59
STAT3 IL6-mediated signaling events pid 48
STAT3 IL6 netpath 85
STAT3 IL9 netpath 24
STAT3 Inflammation mediated by chemokine and cytokine signaling pathway panther 189
STAT3 Interleukin-6 signaling reactome 11
STAT3 Interleukin signaling pathway panther 86
STAT3 JAK-STAT pathway and regulation pathway ( JAK-STAT pathway and regulation pathway Diagram ) inoh 97
STAT3 JAK/STAT signaling pathway panther 15
STAT3 KitReceptor netpath 104
STAT3 Leptin netpath 98
STAT3 LIF signaling pathway ( LIF signaling(JAK1 JAK2 STAT3) ) inoh 10
STAT3 Neurotrophic factor-mediated Trk receptor signaling pid 63
STAT3 Notch-mediated HES/HEY network pid 48
STAT3 Notch netpath 76
STAT3 PDGF signaling pathway panther 113
STAT3 PDGFR-beta signaling pathway pid 125
STAT3 Positive regulation of (Transcription of SOCS by STAT dimer) in JAK STAT pathway ( JAK-STAT pathway and regulation pathway Diagram ) inoh 178
STAT3 POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation reactome 13
STAT3 Prolactin netpath 105
STAT3 RAC1 signaling pathway pid 54
STAT3 Ras Pathway panther 69
STAT3 Senescence-Associated Secretory Phenotype (SASP) reactome 108
STAT3 Signaling by cytosolic FGFR1 fusion mutants reactome 18
STAT3 Signaling by Leptin reactome 11
STAT3 Signaling by SCF-KIT reactome 37
STAT3 Signaling events mediated by HDAC Class I pid 89
STAT3 Signaling events mediated by PTP1B pid 53
STAT3 Signaling events mediated by Stem cell factor receptor (c-Kit) pid 53
STAT3 Signaling events mediated by TCPTP pid 40
STAT3 Transcriptional regulation of pluripotent stem cells reactome 28
STAT3 TSH netpath 82
STAT3 TSLP netpath 24
STAT3 Chemokine signaling pathway kegg 187
STAT3 Jak-STAT signaling pathway kegg 149
STAT3 Adipocytokine signaling pathway kegg 65
STAT3 Toxoplasmosis kegg 131
STAT3 Hepatitis C kegg 134
STAT3 Pathways in cancer kegg 321
STAT3 Pancreatic cancer kegg 70
STAT3 Acute myeloid leukemia kegg 53
STAT3 Hs_Interferon_type_I_signaling_pathways_WP585_85198 wikipathways 35
STAT3 Hs_Signaling_of_Hepatocyte_Growth_Factor_Receptor_WP313_79946 wikipathways 15
STAT3 Hs_Leptin_signaling_pathway_WP2034_89856 wikipathways 37
STAT3 Hs_Hepatitis_C_and_Hepatocellular_Carcinoma_WP3646_88640 wikipathways 36
STAT3 Hs_Interleukin-11_Signaling_Pathway_WP2332_79525 wikipathways 17
STAT3 Hs_PDGF_Pathway_WP2526_82681 wikipathways 12
STAT3 Hs_VEGFA-VEGFR2_Signaling_Pathway_WP3888_90000 wikipathways 153
STAT3 Hs_Dopaminergic_Neurogenesis_WP2855_87239 wikipathways 19
STAT3 Hs_Oncostatin_M_Signaling_Pathway_WP2374_73668 wikipathways 44
STAT3 Hs_Amino_Acid_metabolism_WP3925_90737 wikipathways 6
STAT3 Hs_Vitamin_B12_Metabolism_WP1533_85340 wikipathways 33
STAT3 Hs_ESC_Pluripotency_Pathways_WP3931_91005 wikipathways 13
STAT3 Hs_MicroRNAs_in_cardiomyocyte_hypertrophy_WP1544_89794 wikipathways 29
STAT3 Hs_Regulation_of_Microtubule_Cytoskeleton_WP2038_90889 wikipathways 38
STAT3 Hs_Kit_receptor_signaling_pathway_WP304_78799 wikipathways 46
STAT3 Hs_IL-5_Signaling_Pathway_WP127_78498 wikipathways 35
STAT3 Hs_IL-2_Signaling_Pathway_WP49_91243 wikipathways 33
STAT3 Hs_IL-6_signaling_pathway_WP364_89832 wikipathways 26
STAT3 Hs_RalA_downstream_regulated_genes_WP2290_79988 wikipathways 9
STAT3 Hs_IL-4_Signaling_Pathway_WP395_89828 wikipathways 41
STAT3 Hs_Brain-Derived_Neurotrophic_Factor_(BDNF)_signaling_pathway_WP2380_89803 wikipathways 80
STAT3 Hs_EGF-EGFR_Signaling_Pathway_WP437_79266 wikipathways 107
STAT3 Hs_IL-3_Signaling_Pathway_WP286_78583 wikipathways 35
STAT3 Hs_Notch_Signaling_Pathway_WP61_78592 wikipathways 16
STAT3 Hs_IL-9_Signaling_Pathway_WP22_79264 wikipathways 11
KLF4 Regulation of nuclear beta catenin signaling and target gene transcription pid 80
KLF4 Synthesis, secretion, and deacylation of Ghrelin reactome 17
KLF4 Transcriptional regulation of pluripotent stem cells reactome 28
KLF4 Transcriptional regulation of white adipocyte differentiation reactome 79
KLF4 Hs_Role_of_Osx_and_miRNAs_in_tooth_development_WP3971_91525 wikipathways 9
KLF4 Hs_White_fat_cell_differentiation_WP3946_90940 wikipathways 30
KLF4 Hs_Mesodermal_Commitment_Pathway_WP2857_87780 wikipathways 47

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs